BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2004
View Archived Issues
Thiazolidinediones reduce cardiac events in diabetic heart transplant patients
Read More
Specific cannabinoid receptor agonist may prevent tissue damage in retina
Read More
Preliminary evidence for the benefits of aromatase inhibitors in epilepsy
Read More
Levetiracetam reported to reduce the frequency of transformed migraine
Read More
Neuroprotection from focal ischemic injury by TACE inhibitor DPH-067517
Read More
Fludarabine reported effective in controlling break through multiple sclerosis
Read More
Modafinil and interferon beta improve cognitive impairment in relapsing-remitting MS
Read More
BAL-5788 effective against antibiotic-resistant strains of pneumonia
Read More
Statins and fibrates delay cognition decline in AD
Read More
Clinical benefits of tacrolimus in patients with myasthenia gravis
Read More
Interim results from phase II trial of Metastat
Read More
New approval for Enbrel in psoriasis
Read More
MAGNET liver cancer trial stopped early
Read More
Zelnorm labeling updated with new risk information
Read More
UCB-44212 Keppra analogue enters phase I
Read More
Phase I trial evaluates intranasal PTH1-34
Read More
Preliminary results from Oralin clinical study
Read More
Avanir completes initial phase I study of AVP-13358
Read More
Panacea collaborates with M.D. Anderson Cancer Center on HAAH program
Read More
ThPTH successfully tested in first-in-man study
Read More
AMDL seeks partner for Combination Immunogene Therapy
Read More
Peptech and Agenix to merge
Read More
Australian Pentrys phase II trial commences
Read More
Orphan drug status for PI-88 for malignant melanoma
Read More
M-55529: A novel, selective factor Xa inhibitor from Mochida
Read More
Two series of antimycobacterial agents prepared and tested at Lupin
Read More
Merck describes new glucocorticoid receptor modulators and their use
Read More
Novel estrogen receptor modulators under study at Merck
Read More
New urotensin II antagonists covered by Actelion patent
Read More
New adenosine A1 agonists, their preparation and use, reported by GSK team
Read More
New orexin antagonists for obesity and sleep disorders claimed by GSK
Read More